Financial Analysis · 23Aeglea Biotherapeutics — Redefining the Possible. Human Enzyme Therapies for People with Rare Diseases · Slide 232023
Financial Analysis · 26Aeglea Biotherapeutics — Redefining the Possible. Human Enzyme Therapies for People with Rare Diseases · Slide 262023